THE JOURNAL OF KOREAN ORIENTAL ONCOLOGY (대한한방종양학회지)
- Volume 4 Issue 1
- /
- Pages.147-158
- /
- 1998
- /
- 1229-2621(pISSN)
Clinical study in 40 cases for patients with stomach cancer taken Hangammyunyouk I (抗癌免疫1號方)
항암면역(抗癌免疫) 1호방(號方)을 투여(投與)한 위암환자(胃癌患者) 40례(例)에 대(對)한 임상고찰(臨床考察)
- Yoo, Hwa-Seung (Dept. of Oriental Internal Medicine, the College of Oriental Medicine, Taejon University) ;
- Jo, Jeong-Hyo (Dept. of Oriental Internal Medicine, the College of Oriental Medicine, Taejon University) ;
- Gwak, Gyeong-Gyu (Dept. of Oriental Internal Medicine, the College of Oriental Medicine, Taejon University) ;
- Lee, Yeon-Wol (Dept. of Oriental Internal Medicine, the College of Oriental Medicine, Taejon University) ;
- Jo, Jin-Ho (Dept. of Oriental Internal Medicine, the College of Oriental Medicine, Taejon University) ;
- Cho, Chong-Kwan (Dept. of Oriental Internal Medicine, the College of Oriental Medicine, Taejon University)
- Published : 1998.12.21
Abstract
Clinical studies were carried out 40 cases of patients with stomach cancer treated by "Hangammyunyouk I(抗癌免疫1號方)", from September 1th 1997 to May 1th 1998. The results were summarized as follows; 1. Distribution of those attached by stomach cancer, by sex, showed that Male is more then Female, by age, showed that the number of fifties is majority. 2. Distribution of diagnostic stage, on descending order, stage III, stage IV. 3. Distribution of treatment attached by stomach cancer, in descending order: Chemotherapy and operation, chemotherapy, Radiation therapy and operation. 4. After taken herb medicine, the effects according to the symptoms were as follows; Nausea and Vomiting, Constipation, General body weakness, Average efficacy of symptoms were 68.1%. 5. Analysis of hematology attached by stomach cancer, increasing of WBC(61.5%), Hgb(54.5%), Platelet(62.5%) were observed.